PSMA diagnostics and treatments of prostate cancer become mature
| Autor: | Finn Edler von Eyben, Glenn Stewart Baumann, Richard P. Baum |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Oncology
medicine.medical_specialty medicine.medical_treatment Salvage treatment urologic and male genital diseases 030218 nuclear medicine & medical imaging 03 medical and health sciences Prostate cancer 0302 clinical medicine 117Lu-PSMA-617 RLT Prostate Internal medicine medicine Radiology Nuclear Medicine and imaging 68Ga HBED-CC PET/CT External beam radiotherapy Spotlight medicine.diagnostic_test business.industry Prostatectomy Poorly differentiated Interventional radiology medicine.disease Radiation therapy medicine.anatomical_structure 030220 oncology & carcinogenesis business |
| Zdroj: | Clinical and Translational Imaging |
| ISSN: | 2281-7565 2281-5872 |
| Popis: | Prostate cancer is the second leading cause of cancer death for men in many parts of the world. Radical prostatectomy (RP) and external beam radiotherapy (EBRT) are effective treatment of localized prostate cancer but many patients recur with raising levels of prostate-specific antigen (PSA). Localized salvage therapies for suspected local failure such as salvage EBRT after RP are most effective during early PSA recurrence. In a Danish national cohort study, salvage EBRT for patients with PSA recurrence after RP undertaken without restaging imaging was effective for approximately half of the patients [1]. Improving on these results requires identification of men with truly localized or oligometastatic recurrence. However, restaging with conventional imaging such as CT and bone scans has limitations. For example, among patients with PSA recurrence after RP, those with a rising PSA |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink